Coeptis Therapeutics Holdings, Inc. - Common Stock (COEP)
10.70
-0.36 (-3.25%)
Coeptis Therapeutics Holdings Inc. is a biopharmaceutical company focused on developing innovative therapies for cancer patients
The company leverages advanced technologies and scientific expertise to create personalized treatment solutions that aim to improve patient outcomes. Coeptis is dedicated to transforming the landscape of cancer care through its commitment to research and development, actively collaborating with academic institutions and other industry leaders to bring promising therapies from the lab to the clinic. By prioritizing patient-centric approaches, Coeptis seeks to address unmet medical needs in oncology and advance the standard of care for those affected by cancer.
The Dow Jones index closed lower by around 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
The Dow Jones closed lower by over 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
